Petah Tikva-based DreaMed Diabetes has just received FDA 510(k) clearance for MODI, a prescription medical application that automatically optimizes insulin dosing for adults with type 2 diabetes. | Read More in JPost.com – Business & Innovation | The Jerusalem Post
Five suspects in RAF Fairford bomb plot released on bail, UK probing possible Iran ties
IDF braces for Hamas kidnapping attempt along Gaza’s Yellow Line
Palestinian security officer suspected in Qalqilya tunnel case near central Israel
Suspects in foiled UK airbase terror plot released on bail as Iran denies involvement
Israel reprimands Spanish envoy after minister says Palestine should be free ‘from river to sea’
Goldknopf’s move could shatter Netanyahu’s haredi alliance
Irregular complaint | Shin Bet demands harsh measures against Channel 12 News
Record number of countries absent from UN Durban Event
Ronen Bar: I will file a defamation lawsuit against Netanyahu